188 related articles for article (PubMed ID: 35347552)
1. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
Botsali A; Esme P; Erbil H; Caliskan E
Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
[TBL] [Abstract][Full Text] [Related]
2. Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial.
Mokhtari F; Bahrami B; Faghihi G; Asilian A; Iraji F
J Dermatolog Treat; 2022 Aug; 33(5):2475-2481. PubMed ID: 34387527
[TBL] [Abstract][Full Text] [Related]
3. A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma.
Otb S; Shaarawy E; Sadek A; Abdallah N; Agamia N; Soliman M; Tawfik AA
J Dermatolog Treat; 2022 Feb; 33(1):555-559. PubMed ID: 32420770
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized controlled trial of Q-switched Nd:YAG laser with topical 3% tranexamic acid (TA) versus microneedling with topical 3% tranexamic acid (TA) in treatment of melasma.
Debasmita B; Raj C; Ishan A; Ipsita D
J Cosmet Dermatol; 2022 Jul; 21(7):2801-2807. PubMed ID: 34636493
[TBL] [Abstract][Full Text] [Related]
5. A comparative study between oral tranexamic acid versus oral tranexamic acid and Q-switched Nd-YAG laser in melasma treatment: a clinical and dermoscopic evaluation.
Agamia N; Apalla Z; Salem W; Abdallah W
J Dermatolog Treat; 2021 Nov; 32(7):819-826. PubMed ID: 31908179
[TBL] [Abstract][Full Text] [Related]
6. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.
Elkamshoushi AM; Romisy D; Omar SS
J Cosmet Dermatol; 2022 Feb; 21(2):657-668. PubMed ID: 33826785
[TBL] [Abstract][Full Text] [Related]
7. Comparison of efficacy and safety of tranexamic acid mesotherapy versus oral tranexamic acid in patients with melasma undergoing Q-switched fractional 1064-nm Nd:YAG laser: A blinded RCT and follow-up.
Behrangi E; Shemshadi M; Ghassemi M; Goodarzi A; Dilmaghani S
J Cosmet Dermatol; 2022 Jan; 21(1):279-289. PubMed ID: 34724323
[TBL] [Abstract][Full Text] [Related]
8. A split-face comparison of fractional erbium: YAG laser plus Kligman's formula vs. Kligman's formula monotherapy for facial melasma.
Nasimi M; Ghiasi M; Lajevardi V; Nasiri F; Shakoei S
Arch Dermatol Res; 2022 Oct; 314(8):791-797. PubMed ID: 34705101
[TBL] [Abstract][Full Text] [Related]
9. The efficacy in treatment of facial melasma with thulium 1927-nm fractional laser-assisted topical tranexamic acid delivery: a split-face, double-blind, randomized controlled pilot study.
Wanitphakdeedecha R; Sy-Alvarado F; Patthamalai P; Techapichetvanich T; Eimpunth S; Manuskiatti W
Lasers Med Sci; 2020 Dec; 35(9):2015-2021. PubMed ID: 32506227
[TBL] [Abstract][Full Text] [Related]
10. Split-face comparative study between intradermal tranexamic acid injection alone versus intradermal tranexamic acid injection combined with Q-switched Nd:YAG laser in melasma treatment: dermoscopic and clinical evaluation.
Hawwam SA; Ismail M; El-Attar YA
Lasers Med Sci; 2022 Jun; 37(4):2193-2201. PubMed ID: 34988730
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma.
Abdel-Raouf Mohamed H; Ali Nasif G; Saad Abdel-Azim E; Abd El-Fatah Ahmed M
J Cosmet Dermatol; 2019 Apr; 18(2):517-523. PubMed ID: 30146730
[TBL] [Abstract][Full Text] [Related]
12. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
Laothaworn V; Juntongjin P
J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
[No Abstract] [Full Text] [Related]
13. Evaluating the tolerance and efficacy of laser-assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split-face trial.
Park SJ; Park JW; Seo SJ; Park KY
Dermatol Ther; 2022 Mar; 35(3):e15287. PubMed ID: 34962047
[TBL] [Abstract][Full Text] [Related]
14. Assessment of combined fractional CO
Tawfic SO; Abdel Halim DM; Albarbary A; Abdelhady M
Lasers Surg Med; 2019 Jan; 51(1):27-33. PubMed ID: 30431171
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of laser and topical tranexamic acid combination therapy in melasma: An updated systematic review and meta-analysis of randomized controlled trials.
Khan QA; Abdi P; Farkouh C; Anthony MR; Chundru A; Amatul F; Parimi K; Santiago N; Farkouh M; Iram S; Khan A
Lasers Med Sci; 2023 Jun; 38(1):139. PubMed ID: 37326860
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the of the efficacy of Fractional Erbium-Doped Yttrium Aluminum Garnet Laser-Assisted Drug Delivery of Kojic Acid in the Treatment of Melasma; A split face, comparative clinical study.
Al-Dhalimi MA; Yasser RH
J Cosmet Laser Ther; 2021 May; 23(3-4):65-71. PubMed ID: 34407729
[TBL] [Abstract][Full Text] [Related]
17. Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma: A split-face study.
Mekawy KMM; Sadek A; Seddeik Abdel-Hameed AK
J Cosmet Dermatol; 2021 Feb; 20(2):460-465. PubMed ID: 32562337
[TBL] [Abstract][Full Text] [Related]
18. Combining Low Power Fractional CO
Esmat S; Z Elramly A; Shahin D; Hilal RF
Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829
[TBL] [Abstract][Full Text] [Related]
19. Laser-assisted delivery of tranexamic acid for melasma: Pilot study using a novel 1927 nm fractional thulium fiber laser.
Wang JV; Christman MP; Feng H; Ferzli G; Jeon H; Geronemus RG
J Cosmet Dermatol; 2021 Jan; 20(1):105-109. PubMed ID: 33174686
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of laser-assisted delivery of tranexamic acid for the treatment of melasma: a systematic review and meta‑analysis.
Feng J; Shen S; Song X; Xiang W
J Cosmet Laser Ther; 2022 Nov; 24(6-8):73-79. PubMed ID: 36403155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
